TMCI

Treace Medical Concepts Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 1/10
  • Value↓ 1/10
Treace Medical Concepts sales and earnings growth
TMCI Growth
Low
  • Revenue Y/Y↓ -4.66%
  • EPS Y/Y↓ -12.94%
  • FCF Y/Y↑ 29.75%
Treace Medical Concepts gross and profit margin trends
TMCI Profitability
Low
  • Gross margin ↑ 79.70%
  • EPS margin↓ -29.40%
  • ROIC 5Y↓ -22.30%
Treace Medical Concepts net debt vs free cash flow
TMCI Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 2.3
  • Interest coverage↓ -9.9

Treace Medical Concepts stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Medical Devices stocks